Peptide Therapy Marketing · Sermorelin

Sermorelin Patient Lead Generation for Peptide Clinics

Written byTamerlan Musayev·Founder of PeptideLeads

Sermorelin is often the first growth hormone releasing peptide patients discover, which makes it a gateway category. Patients searching for it are usually new to peptides but not new to optimization. They have been on TRT, they have been tracking biomarkers, and they are now looking for the next lever. PeptideLeads routes these patients to your clinic for $50 per qualified lead. No retainer, we cover all ad spend, and founder Tamerlan Musayev built the model to give peptide clinics a reliable way to reach patients at this exact moment in their research.

The Market Context

Sermorelin has been on the market longer than most peptides, which gives it broader recognition but also more competition. The typical Sermorelin patient is male, 40 to 60, income above average, and motivated by visible outcomes like body composition, energy, and sleep. A growing secondary segment is women of similar age looking at it for menopause-adjacent concerns. Monthly branded search volume runs between 50,000 and 90,000 in the United States, with steady demand year-round and peaks in January. Because Sermorelin is FDA-approved for pediatric growth hormone deficiency, the regulatory language is cleaner than some newer peptides, which means ads can be more direct.

Why This Works

Sermorelin patients often become repeat customers across multiple peptide categories. The initial Sermorelin protocol frequently leads to exploration of CJC-1295, Ipamorelin, or combination stacks. That means the first-year revenue per Sermorelin patient is usually higher than the first protocol alone suggests, landing between $2,500 and $5,500 on average. At $50 per lead with close rates in the 30 to 40 percent range, cost of acquisition stays well under $175. Against recurring revenue, the math works in any local market.

How Our Process Works

We run Sermorelin campaigns on Meta and Google with creative that speaks to the specific outcomes patients care about. We qualify every lead on state, prior hormone therapy experience, goals, and start timeline. Phone numbers are verified before delivery. You receive complete lead profiles. We cover the ad spend. You pay $50 per qualified lead.

What Makes Us Different

Sermorelin is sometimes dismissed by clinics as old news, but the patient demand is still there and the ad costs are often lower than for newer peptides. That makes it one of the most efficient categories for clinics that want high volume at low cost per acquisition. We know how to run Sermorelin campaigns that attract actual buyers rather than generic wellness tire-kickers. That operational knowledge is what separates us from general marketing agencies.

$50 Per Lead. No Retainer. We Cover All Ad Spend.

If your clinic offers Sermorelin and wants a steady flow of qualified patients, let's talk. $50 per lead, no retainer, full ad spend coverage.

Book a 30-Minute Call Get Matched

Frequently Asked Questions

Is Sermorelin still in demand given newer peptides?

Yes. Sermorelin has recognizable brand equity and remains a gateway for patients new to growth hormone releasing peptides. Search volume is stable.

What does a Sermorelin lead include?

Full name, phone, email, state, prior hormone therapy history, goals, and preferred start date. Phone is verified before delivery.

How does Sermorelin lead cost compare to other peptides?

Sermorelin campaigns often run at lower cost per lead than BPC-157 or Semaglutide because the ad language is cleaner. The $50 flat rate we charge is usually well within our internal cost envelope.

Do you cover all ad spend?

Yes. You pay $50 per qualified lead and nothing else.

Is there a minimum volume?

No. No retainer, no minimum, no contract.